Phreesia (PHR) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Phreesia

NYSE•Healthcare•Health Information Services

$10.94-0.16(-0.01%)Market closed

Market Cap

$621.26M

P/E

59.5x

P/S

1.2x

P/B

1.7x

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. It offers solutions including appointment optimization and referral management using AI-enabled workflows; and AI-based smart answering solution patient communications supported by voice and messaging solutions; integrated payment solutions embedded in intake and post-visit workflows, and financing solutions that enable healthcare organizations to accelerate cash collections while offering flexible payment options to patients; and digital intake and clinical data capture, patient engagement and activation tools, and measurement and analytics solutions. It also offers PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, which are on-site kiosks. The company serves a range of healthcare organizations including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest and not-for-profit and other organizations. Phreesia, Inc. was incorporated in 2005 and is based in Wilmington, Delaware.

How this company scores

ExcellentMetricSide Score: 80/100

Strongest: Cash & Earnings Quality (25/25); weakest: Profitability (13/25).

Profitability13/25

Growth20/25

Balance Sheet & Red Flags22/25

Cash & Earnings Quality25/25

Strengths

Rising free cash flowRising earningsLow leverageCash-backed earnings

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 59.5x5y range 59.5x – 351.9x

P/S · 1.2x5y range 1.2x – 18.3x

Currently below its 20-quarter median.

P/B · 1.7x5y range 1.6x – 7.9x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Margin Pressure

Red Flag

The company posted negative operating margins in recent quarters — core operations are unprofitable.

Earnings Quality

Watch

FCF/Net Income has dropped below 0.7x in 3 quarters — monitor for earnings quality deterioration.

Price & Volume

Market Cap $621.26M

Metrics at a Glance

as of July 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $507.79M
Q. Revenue: $129.46M
TTM EBITDA: $49.65M
TTM Op. Income: $12.54M
Q. Op. Income: $7.61M
TTM Net Income: $10.45M
Q. Net Income: $1.92M
EPS: $0.03
Shares Out.: $61.88M

$507.79M in TTM revenue grew 12.9% YoY, reaching $129.46M last quarter. TTM EBITDA of $49.65M and TTM operating income of $12.54M show growth is flowing through to the bottom line. TTM net income of $10.45M means revenue is converting into profit. Across the last 8 quarters, TTM revenue has risen for 7 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 85.1%
EBITDA Margin: 13.6%
Op. Margin: 5.9%
Net Margin: 1.5%

Op. margin of 5.9% is up 7.2% YoY — cost efficiency is improving. Net margin at 1.5% and gross margin of 85.1% show how much of each revenue dollar survives to profit. Across the last 8 quarters, operating margin has risen for 2 consecutive quarters — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 59.5x
P/S Ratio: 1.2x
P/B Ratio: 1.7x

At 59.5x P/E, the stock trades above typical market levels — the market expects above-average growth. P/S of 1.2x and P/B of 1.7x provide additional context. Use the growth and margin sections to judge whether the multiple is justified. Across the last 3 quarters, P/E has fallen for 2 consecutive quarters — an improving trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $646.98M
Cash: $74.64M
Long-Term Debt: $1.14M
Book Value: $371.85M
D/E Ratio: 0.0
Debt/EBITDA: 0.1

With $646.98M in assets and $1.14M in long-term debt, D/E is 0.0and book value is $371.85M — a conservative capital structure with a cushion to weather downturns. Over the past year, debt/equity is down 30% — a weakening trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $18.33M
TTM Free Cash Flow: $80.75M
FCF Margin: 15.9%
FCF / Net Income: 7.7

TTM FCF of $80.75M on $18.33M in operating cash flow. The FCF / Net Income ratio of 7.7x means free cash flow covers net income — earnings are backed by cash. Across the last 8 quarters, free cash flow has risen for 7 consecutive quarters — an improving trend.